All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX003 | Anti-Aquaporin-4 (XR1) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | XR1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX004 | Anti-Aquaporin-4 (XR2) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | XR2 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX006 | Anti-Aquaporin-4 (XR4) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | XR4 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX007 | Anti-Aquaporin-4 (E5415A) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | E5415A | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX008 | Anti-Aquaporin-4 (XR5) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | XR5 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX009 | Anti-Aquaporin-4 (XR1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | XR1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX010 | Anti-Aquaporin-4 (XR2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | XR2 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX012 | Anti-Aquaporin-4 (XR4) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | XR4 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX013 | Anti-Aquaporin-4 (E5415A) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | E5415A | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX014 | Anti-Aquaporin-4 (XR5) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | XR5 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION